These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 14740279

  • 1. Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits.
    Coscelli C, Iacobellis G, Calderini C, Carleo R, Gobbo M, Di Mario U, Leonetti F, Galluzzo A, Pirrone V, Lunetta M, Casale P, Paleari F, Falcelli C, Valle D, Camporeale A, Merante D.
    Acta Diabetol; 2003 Dec; 40(4):187-92. PubMed ID: 14740279
    [Abstract] [Full Text] [Related]

  • 2. Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.
    Malone JK, Yang H, Woodworth JR, Huang J, Campaigne BN, Halle JP, Yale JF, Grossman LD.
    Diabetes Metab; 2000 Dec; 26(6):481-7. PubMed ID: 11173719
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitus.
    Roach P, Arora V, Campaigne BN, Mattoo V, Rangwala S, India Mix25/Mix50 Study Group.
    Diabetes Obes Metab; 2003 Sep; 5(5):311-6. PubMed ID: 12940868
    [Abstract] [Full Text] [Related]

  • 6. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
    Niskanen L, Jensen LE, Råstam J, Nygaard-Pedersen L, Erichsen K, Vora JP.
    Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
    [Abstract] [Full Text] [Related]

  • 7. Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: a multicountry application of a discrete choice experiment.
    Aristides M, Weston AR, FitzGerald P, Le Reun C, Maniadakis N.
    Value Health; 2004 Apr; 7(4):442-54. PubMed ID: 15449636
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.
    Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.
    Diabetes Care; 2002 May; 25(5):883-8. PubMed ID: 11978685
    [Abstract] [Full Text] [Related]

  • 11. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z, Romania/Russia Mix25 Study Group.
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Higher morning to evening ratio in total dose of twice-daily biphasic insulin analog might be effective in achieving glucose control in patients with poorly controlled type 2 diabetes.
    Lee YH, Lee BW, Kwon HJ, Kang ES, Cha BS, Lee HC.
    Diabetes Technol Ther; 2012 Jun; 14(6):508-14. PubMed ID: 22376081
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan.
    Mattoo V, Milicevic Z, Malone JK, Schwarzenhofer M, Ekangaki A, Levitt LK, Liong LH, Rais N, Tounsi H, Ramadan Study Group.
    Diabetes Res Clin Pract; 2003 Feb; 59(2):137-43. PubMed ID: 12560163
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients.
    Boehm BO, Home PD, Behrend C, Kamp NM, Lindholm A.
    Diabet Med; 2002 May; 19(5):393-9. PubMed ID: 12027927
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.